Please login to the form below
Data scientists
This page shows the latest Data scientists news and features for those working in and with pharma, biotech and healthcare.
Researchers create ‘world’s largest’ database for predicting cancer treatment response
experts, software engineers, data scientists, cancer cell biologists, and oncology researchers that has resulted in important new insights into the interactions among thousands of key molecules within cancer cells, and the
Latest news
-
Eli Lilly launches the Institute for Genetic Medicine and a $700m facility investment
Projections made by the company cover a five-year time frame, as it expects the Boston site to grow from 120 to more than 250 chemists, data scientists and research biologists ... The New York site is expected to expand to include up to 200 scientists,
-
New data from Moderna supports COVID boosters
The politics of booster programmes has been highlighted in a paper published in the Lancet by a group of renowned international scientists, which reviewed all existing published data on COVID vaccine ... Careful and public scrutiny of the evolving data
-
UK approves Regeneron’s COVID-19 antibody cocktail
by our expert scientists and clinicians, we are satisfied that this treatment is safe and effective. ... With no compromises on quality, safety and efficacy, the public can trust that the MHRA has conducted a robust and thorough assessment of all the
-
AbbVie, Biogen and Pfizer collaboration creates new resource for genetic exome sequence analysis
The results of this engagement with the Broad Institute can now be freely accessed via the browser, enabling scientists to explore and use the data in research – in accordance with the ... the path from genetic discoveries towards novel
-
W2O rebrands as ‘health innovation company’ Real Chemistry
Real Chemistry has over 400 analysts, digital experts and data scientists, with its Health Technologies division housing a portfolio of proprietary technology products, including Swoop, IPM.ai and Symplur Suite.
More from news
Approximately 1 fully matching, plus 28 partially matching documents found.
Latest Intelligence
-
Unlocking the potential of data sharing
assessments. With the advent of increasingly sophisticated ways to process the data, scientists can now utilise platforms that share information instantly, enabling real-time assessments of patient safety and trial outcomes. ... Dilshat Djumanov is
-
Building a brighter future with patient support programmes
PSPs and their ability to connect pharma, healthcare professionals (HCPs) and patients, and energise remote monitoring and data generation. ... Valuing patient data. VISFO, which has health economists, medics, data scientists, immunologists and software
-
The decentralisation of clinical trials is a key catalyst for innovation in artificial intelligence
Even the relatively repetitive tasks of clinical data management, where clinical trial databases must be carefully curated, cleaned and standardised for statistical analysis, are coming under the eye of data scientists. ... The digitisation of all
-
Exploiting the value of data in pharma
Applying advanced analytics with teams of data scientists, as well as iterative approaches, has already cut elapsed time for drug trials. ... Being able to process and make sense of wider data sets and apply advanced analytics technology alongside a
-
Has AI been the key to tackling the COVID-19 pandemic?
If there is one thing AI excels in, it is analysing and uncovering patterns in huge swathes of data. ... Finding a cure. Data scientists and researchers require tools that will help them find relevant insights among masses of historical data and pieces
More from intelligence
Approximately 0 fully matching, plus 10 partially matching documents found.
Latest from PMHub
-
Actionable Insights for Medical Affairs: Elusive or Within Reach?
MMA’s skilled data scientists are able to plumb the depths of data to find patterns in health behaviors and recognize trends that identify and determine ways that clinical care and ... Dash S, Shakyawar S, Sharma M, et al. Big data in healthcare;
-
Envision Pharma Group and Vitaccess create a global partnership to power evidence generation for the biopharmaceutical industry
An increasing requirement for data leads to a growing need for more adaptive RWE research to be generated and communicated to regulators, pre and post approval. ... We are health economists, researchers, eClinical health experts, data scientists,
-
Delivering outcomes-led solutions with connected capabilities
We put brands front of mind. No matter where a brand or portfolio of brands may be in their lifecycle, our team of strategists, scientists, data analysts and creatives are masters ... From market performance to prescription and bespoke data sets, we
-
Newcells Biotech secures over £5m for 3D tissue models
This pioneering modelling technology improves the ability to generate data on the safety, efficacy, and pharmacology of drugs prior to human trials. ... Whether it be in understanding how new drugs interact with the kidney or the retina, our scientists
-
#DemandDiversity: The science behind diversity
The results found that, overall, 45 of 58 studies in the sample excluded minority data. ... By excluding data from minority populations, scientists are losing the opportunity to build knowledge about health conditions in different ethnicities, and
More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.
Subscribe to our email news alerts
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- PMGroup announces launch of new recruitment platform PharmaRole
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- BioNTech reveals plans to spend about €1bn more on research and development this year
- AstraZeneca’s mild combination asthma reliever approved in UK
- Virtual Patient Engagement Program: A Customer Story
- Putting Skin in the Game at AAD 2023
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Inizio appoints Stefanie Christmas as global head of DE&I
- The Considered appoints Bam Zahraie as chief experience officer
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
